BioMS Medical becomes Medwell Capital Corp.

On July 6, 2010 BioMS Medical Corp. (TSX: MS) reported it has changed its name to Medwell Capital Corp. ("Medwell" or "the Company") (Press release, BioMS Medical, JUL 6, 2010, View Source [SID:1234510643]). Shares of Medwell will continue trading on the Toronto Stock Exchange under the symbol ‘MS’ until the end of the trading on July 7, 2010. On Thursday, July 8, 2010, Medwell will begin trading under the new symbol ‘MWC’.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The name change was approved by shareholders at the Company’s annual meeting held on June 25, 2010.

About Medwell Capital Corp.

Medwell Capital Corp. is a Canadian-based service provider in the healthcare industry. For further information please visit www.medwellcapital.com.

This press release may contain forward-looking statements, which reflect the Company’s current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation’s ongoing quarterly and annual reporting. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.